Animal Science Products v. Hebei Welcome Pharmaceuticals
Animal Science Products v. Hebei Welcome Pharmaceuticals | |
---|---|
Holding | |
A federal court must provide respectful consideration to a foreign government's representation of its own law, but not conclusive effect. | |
Court membership | |
| |
Case opinion | |
Majority | Ginsburg, joined by unanimous |
Laws applied | |
Federal Rule of Civil Procedure 44.1 |
Animal Science Products v. Hebei Welcome Pharmaceuticals, 585 U.S. ___ (2018), was a case before the
international comity, deferred to China's representation of its own law, provided that this representation was "reasonable".[1] In a unanimous opinion, the Supreme Court reversed the ruling of the Second Circuit, finding that respectful consideration must be granted to a foreign government's statements, but not conclusive effect.[2] The case marked the first occasion that the Chinese government appeared as an amicus curiae in oral argument before the US Supreme Court, and was the third time that any foreign government had done so.[3]
References
- ^ "Animal Science Products, Inc. v. Hebei Welcome Pharmaceutical Co. Ltd. | Oyez". Oyez. Retrieved July 29, 2018.
- ^ Animal Science Products v. Hebei Welcome Pharmaceuticals, No. 16-1220, 585 U.S. ___ (2018).
- ^ Frankel, Alison (April 16, 2018). "Chinese, U.S. governments to face off in SCOTUS trade skirmish". Reuters. Retrieved July 29, 2018.
External links
- Text of Animal Science Products v. Hebei Welcome Pharmaceuticals, 585 U.S. ___ (2018) is available from: Google Scholar Justia Oyez (oral argument audio) Supreme Court (slip opinion)